Arsanis, Inc. Uncategorized Contracts & Agreements
22 Contracts & Agreements
- Form of Pre-Funded (Filed With SEC on March 3, 2022)
- Third Amendment to Option Agreement, dated July 15, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP (Filed With SEC on July 15, 2021)
- Second Amendment to Option Agreement, dated June 7, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP (Filed With SEC on June 7, 2021)
- First Amendment to Option Agreement dated May 3, 2021, by and between X4 Pharmaceuticals Inc. and Abingworth Bioventures 8 LP (Filed With SEC on May 6, 2021)
- Description of Registered Securities (Filed With SEC on March 19, 2021)
- Option Agreement, dated March 18, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP (Filed With SEC on March 19, 2021)
- Description of Registered Securities (Filed With SEC on March 12, 2020)
- Form of Support Agreement, dated November 26, 2018, by and among Arsanis, Inc., X4 Pharmaceuticals, Inc. and certain stockholders of Arsanis, Inc (Filed With SEC on November 27, 2018)
- Form of Support Agreement, dated November 26, 2018, by and among Arsanis, Inc., X4 Pharmaceuticals, Inc. and certain officers, directors and stockholders of X4 Pharmaceuticals, Inc (Filed With SEC on November 27, 2018)
- Letter Agreement, dated November 26, 2018, by and between Arsanis, Inc. and Ren Russo (Filed With SEC on November 27, 2018)
- Amended and Restated Agreement, dated August 8, 2018, by and between the Registrant and the Bill & Melinda Gates Foundation (Filed With SEC on August 13, 2018)
- Grant Agreement, dated August 8, 2018, by and between the Registrant and the Bill & Melinda Gates Foundation (Filed With SEC on August 13, 2018)
- ARSANIS, INC. SECONDAMENDED AND RESTATED STOCKHOLDERS AGREEMENT Dated as of April 12, 2016 Amended as of November 3, 2017 TABLE OF CONTENTS (Filed With SEC on November 6, 2017)
- Offer letter, dated July 12, 2015, by and between the Registrant and Ren Russo (Filed With SEC on October 20, 2017)
- Offer letter, dated January 15, 2016, by and between the Registrant and Michael Gray (Filed With SEC on October 20, 2017)
- Offer letter, dated April 28, 2016, by and between the Registrant and Chris Stevens (Filed With SEC on October 20, 2017)
- Grant Agreement, dated February 20, 2017, by and between the Registrant and Bill & Melinda Gates Foundation, as amended (Filed With SEC on October 20, 2017)
- Letter agreement, dated as of April 24, 2017, by and between the Registrant and Bill & Melinda Gates Foundation (Filed With SEC on October 20, 2017)
- Second Amended and Restated Stockholders Agreement, dated as of April 12, 2016, among the Registrant and the other parties thereto, as amended (Filed With SEC on October 20, 2017)
- Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Ren Russo (to be effective upon the closing of this offering) (Filed With SEC on October 20, 2017)
- Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Michael Gray (to be effective upon the closing of this offering) (Filed With SEC on October 20, 2017)
- Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Chris Stevens (to be effective upon the closing of this offering) (Filed With SEC on October 20, 2017)
